Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Tariff Resilience Score: 0/10 (As of Jul. 20, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600671 Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd SHSE:600671
51 GF Score
Price ¥20.13
GF Value ¥15.01
Valuation Significantly Overvalued
! 10 Warning Signs
View Full Analysis

What is Hangzhou TianMuShan Pharmaceutical Enterprise Co Tariff Resilience Score?

Hangzhou TianMuShan Pharmaceutical Enterprise Co has the Tariff Resilience Score of 0, which implies that the company might have .

Hangzhou TianMuShan Pharmaceutical Enterprise Co has

Tariff Resilience Score is a ranking system developed by GuruFocus to measure a company's exposure to international trade tariffs, rated on a scale from 0 to 10. It takes into account key factors such as global supply chain dependencies, manufacturing locations versus sales markets, import / export balance and percentage of revenue, and more.

The company's exposure to international trade tariffs based on these criteria:

1. Global supply chain dependencies
2. Manufacturing locations versus sales markets
3. Import/export balance and percentage of revenue
4. Historical impact from previous tariff changes
5. Available mitigation strategies (alternative suppliers, pricing power)
6. Industry-specific tariff exemptions or vulnerabilities

Based on the research, GuruFocus believes Hangzhou TianMuShan Pharmaceutical Enterprise Co might have .


Hangzhou TianMuShan Pharmaceutical Enterprise Co  (SHSE:600671) Tariff Resilience Score Explanation

The Tariff Resilience Score ranges from 0 to 10, with 10 as the most resilient. GuruFocus divided Moat Score into following 3 categories:

Tariff Resilience Score Resilience Level
7 - 10Highly Resilient
4 - 6Average Resilient
0 - 3Highly Vulnerable

Hangzhou TianMuShan Pharmaceutical Enterprise Co Tariff Resilience Score Related Terms

SHSE:600671
51GF Score
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd SHSE:600671
Tariff Resilience Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Hangzhou TianMuShan Pharmaceutical Enterprise Co (SHSE:600671) Overvalued in 2026?

Based on GuruFocus' analysis, Hangzhou TianMuShan Pharmaceutical Enterprise Co stock appears to be overvalued. The current stock price of ¥20.13 is trading 34.1% above its estimated GF Value™ of ¥15.01. GuruFocus considers Hangzhou TianMuShan Pharmaceutical Enterprise Co to be Significantly Overvalued.

Key valuation signals for SHSE:600671:

  • Tariff Resilience Score: 0
  • GF Value™: ¥15.01 vs. price of ¥20.13 (34.1% above fair value)
  • GF Score™: 51/100 with 10 warning signs

No single metric tells the full story. See the SHSE:600671 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Hangzhou TianMuShan Pharmaceutical Enterprise Co Business Description

Address No.18 Shangyang Road, Jinnan Street, Lin'an District, Zhejiang Province, Hangzhou, CHN, 311200
Hangzhou TianMuShan Pharmaceutical Enterprise Co Ltd is engaged in producing proprietary Chinese medicines, biopharmaceuticals, healthy foods, medical equipment, and other medicines in China.
51GF Score

Get the complete analysis for SHSE:600671

Tariff Resilience Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥20.13
Price
¥15.01
GF Value